Total Payments
$29,469
2024 Payments
$8,090
Companies
13
Transactions
78
Medicare Patients
519
Medicare Billing
$103,896
Payment Breakdown by Category
Other$22,885 (77.7%)
Travel$3,871 (13.1%)
Food & Beverage$2,016 (6.8%)
Consulting$501.00 (1.7%)
Research$112.63 (0.4%)
Education$83.26 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,885 | 10 | 77.7% |
| Travel and Lodging | $3,871 | 5 | 13.1% |
| Food and Beverage | $2,016 | 59 | 6.8% |
| Consulting Fee | $501.00 | 1 | 1.7% |
| Unspecified | $112.63 | 1 | 0.4% |
| Education | $83.26 | 2 | 0.3% |
Payments by Type
General
$29,356
77 transactions
Research
$112.63
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28,300 | 42 | $0 (2024) |
| HeartFlow, Inc. | $265.36 | 1 | $0 (2023) |
| Mallinckrodt LLC | $167.73 | 3 | $0 (2018) |
| Insmed, Inc. | $159.40 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $128.24 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $125.79 | 3 | $0 (2021) |
| United Therapeutics Corporation | $112.63 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $95.88 | 6 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $50.30 | 6 | $0 (2019) |
| Advanced Respiratory, Inc | $20.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,090 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,090) |
| 2023 | $265.36 | 1 | HeartFlow, Inc. ($265.36) |
| 2022 | $216.86 | 2 | United Therapeutics Corporation ($112.63) |
| 2021 | $125.79 | 3 | Astellas Pharma US Inc ($125.79) |
| 2020 | $9,987 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,987) |
| 2019 | $6,544 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,291) |
| 2018 | $3,721 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,443) |
| 2017 | $519.51 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($385.74) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,290.00 | General |
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $3,113.03 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $293.47 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $43.03 | General |
| 01/24/2023 | HeartFlow, Inc. | FFRct (Device) | Travel and Lodging | Cash or cash equivalent | $265.36 | General |
| Category: Coronary | ||||||
| 10/15/2022 | United Therapeutics Corporation | TYVASO (Drug) | — | Cash or cash equivalent | $112.63 | Research |
| Study: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis • Category: PAH | ||||||
| 10/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $104.23 | General |
| 12/02/2021 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 10/08/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 10/07/2021 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 11/03/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,015.00 | General |
| 10/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| 10/15/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| 10/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $51.67 | General |
| 01/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| 01/06/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| 12/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $67.06 | General |
| 12/02/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.14 | General |
| 11/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2019 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $139.95 | General |
| 09/27/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Respiratory | ||||||
| 05/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | United Therapeutics Corporation | $112.63 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 74 | 158 | $61,171 | $15,529 |
| 2022 | 3 | 100 | 300 | $86,630 | $25,445 |
| 2021 | 4 | 133 | 361 | $89,432 | $25,986 |
| 2020 | 7 | 212 | 358 | $109,524 | $36,936 |
Total Patients
519
Total Services
1,177
Medicare Billing
$103,896
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 108 | $37,131 | $10,335 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 50 | $24,040 | $5,194 | 21.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 175 | $49,175 | $14,770 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 52 | 91 | $36,673 | $10,455 | 28.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 25 | 34 | $782.00 | $220.71 | 28.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 163 | $44,173 | $13,714 | 31.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 46 | 89 | $34,710 | $10,589 | 30.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 12 | 13 | $8,437 | $1,021 | 12.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 51 | 96 | $2,112 | $661.20 | 31.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 53 | 92 | $52,396 | $16,541 | 31.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 120 | $24,768 | $10,016 | 40.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 33 | 45 | $10,562 | $3,803 | 36.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 27 | $7,588 | $2,845 | 37.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $5,131 | $2,115 | 41.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2020 | 14 | 17 | $5,935 | $711.21 | 12.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $2,278 | $686.16 | 30.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 26 | 33 | $866.00 | $217.82 | 25.2% |
About Anupam Kumar
Anupam Kumar is a Critical Care Medicine healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1982835567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anupam Kumar has received a total of $29,469 in payments from pharmaceutical and medical device companies, with $8,090 received in 2024. These payments were reported across 78 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,885).
As a Medicare-enrolled provider, Kumar has provided services to 519 Medicare beneficiaries, totaling 1,177 services with total Medicare billing of $103,896. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Grand Rapids, MI
- Active Since 07/30/2009
- Last Updated 08/31/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1982835567
Products in Payments
- FFRct (Device) $265.36
- OFEV (Drug) $263.05
- ACTHAR (Biological) $167.73
- TYVASO (Drug) $112.63
- NUCALA (Biological) $90.45
- SYMBICORT (Drug) $57.52
- LONHALA MAGNAIR (Drug) $50.30
- CRESEMBA (Drug) $45.80
- BEVESPI AEROSPHERE (Drug) $38.36
- STIOLTO (Drug) $36.09
- The Vest System Model 105 Home Care (Device) $20.79
- Arikayce (Drug) $19.45
- PRALUENT (Drug) $16.91
- Cook Medical Centesis & Drainage (Device) $14.68
- BREO (Drug) $13.48
- ANORO (Drug) $12.42
- TRELEGY ELLIPTA (Drug) $11.89
- ENTRESTO (Drug) $11.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Grand Rapids
Gustavo Cumbo-Nacheli
Critical Care Medicine — Payments: $575,249
Critical Care Medicine $575,249
Reda Girgis, Md, MD
Critical Care Medicine — Payments: $75,229
Critical Care Medicine $75,229
Dr. Ashley Scott, M.d, M.D
Critical Care Medicine — Payments: $20,098
Critical Care Medicine $20,098
Greg Marco, Md, MD
Critical Care Medicine — Payments: $8,297
Critical Care Medicine $8,297
Sheila Krishnan, D.o, D.O
Critical Care Medicine — Payments: $5,532
Critical Care Medicine $5,532
Glenn Vanotteren, Md, MD
Critical Care Medicine — Payments: $2,290
Critical Care Medicine $2,290